Interv Akut Kardiol. 2020;19(2):117-121 | DOI: 10.36290/kar.2020.028

Coronary stent thrombosis: the problem still persists

František Holm
Fakulta zdravotnických studií, Technická Univerzita Liberec
Kardiologie Na Bulovce, Praha

Coronary stent thrombosis is a feared complication with a relatively high mortality rate. Despite advances in stent type and design and the introduction of novel, more effective antiplatelet drugs, the problem still persists. The paper deals with the pathophysiology of thrombosis, taking into account the patient's clinical condition, lesion characteristics, procedural technical factors, and adjuvant pharmacotherapy. A case report is presented of early stent thrombosis with a fatal outcome.

Keywords: percutaneous coronary intervention, stent thrombosis.

Published: June 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holm F. Coronary stent thrombosis: the problem still persists. Interv Akut Kardiol. 2020;19(2):117-121. doi: 10.36290/kar.2020.028.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. Eng J Med 1987; 316: 701-706. Go to original source...
    2. Nakamura S, Colombo A, Gaglione A, et al. Intracoronary ultrasound observations during stent implantation. Circulation 1994; 89: 2026-2034. Go to original source...
    3. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with ultrasound intravascular guidance. Circulation 1995; 91: 1676-1688. Go to original source...
    4. Burzotta F, Parma A, Pristipino C, at al. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the Optimist study. Eur Hear J. 2008; 29: 3011-3021. Go to original source... Go to PubMed...
    5. Kirtane AJ, Stone GW. How to Minimaze Stent Thrombosis. Corculation 2011; 124: 1283-1287. Go to original source...
    6. Cutlip DE, Windecker S, Mehran R, et al. Clinical end-points in coronary stent trials. a case for standardized definition. Circulation 115; 2344-2351. Go to original source...
    7. D´Ascenzo F, Bollati M, Clementi F, et al. Incidence and predictores of coronary stent thrombosis: evidence from and international collaborative meta-analysis including 30 studies, 221 066 patients, and 4 276 thromboses. Int J Cardiol 2013; 167: 575-584. Go to original source...
    8. van Werkum JW, Heestermans AA, ZUomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009; 53: 1399-1409. Go to original source...
    9. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very later stent thrombosis after drug-eluting stent implantation. Circulation 2007; 115: 2426-2434. Go to original source...
    10. Lee CW, Kang SJ, Park DW, et al. Intravascular ultrasound findings in patients with very later stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010; 55: 1936-1942. Go to original source...
    11. Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. A comparison of the impact of current smoking on 2-year major clinical outcomes of first - and second-generation drug-eluting stents in acute myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry. Medicine (Baltimore) 2019; 98(10): e14797. Go to original source... Go to PubMed...
    12. Zhao XY, Li JX, Tang XF, Xu JJ, Song Y, Jiang L, Chen J, Song L, Gao LJ, Gao Z, Qiao SB, Yang YJ, Gao RL, Xu B, Yuan JQ. Validation of Predictive Value of Patterns of Nonadherence to Antiplatelet Regimen in Stented Patients Thrombotic Risk Score in Chinese Population Undergoing Percutaneous Coronary Intervention: A Prospective Observational Study. Chin. Med. J. 2018; 131(22): 2699-2704. Go to original source... Go to PubMed...
    13. Palmerini T, Biondi-Zoccai G, Riva DD, et al. Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis. Lancet 2012; 379: 1393-1402. Go to original source...
    14. Bangalore S, Toklu B, Amoroso N, et al. Bera metal stents, durable polymer drug eluting stents, and biodegradable polymer dru eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMS 2013; 347: 6625. Go to original source...
    15. Navarese EP, Tandjung K, Claessen B, et al. Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. BMS 2013; 347: 6530. Go to original source... Go to PubMed...
    16. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014; 371(23): 2155-2166. Go to original source...
    17. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. N Engl J Med 2009; 361: 1045-1057. Go to original source...
    18. Stephen DW, Braunwald E, McCabe, et al. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes. N Engl J Med 2007; 357: 2001-2015. Go to original source...
    19. Schüpke S, Neumann FJ, Menichelli M, et al. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. N Engl J Med 2019; 381: 1524-1534. Go to original source...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.